Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,658,150
+$8,747,453 QoQ
Shares Held
78,428
+114.6% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Derivatives in LGND
reported options exposure · as of Mar 31, 2026CallValue
$1,317,690
CallShares
6,600
PutValue
$439,230
PutShares
2,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. LGND ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in LGND
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $439,230 | 2,200 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $15,658,150 | 78,428 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,317,690 | 6,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $1,436,932 | 7,600 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $6,910,697 | 36,551 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,102,429 | 17,514 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $283,424 | 1,600 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $812,925 | 7,151 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $2,169,105 | 25,743 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,575,475 | 62,592 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,278,460 | 87,909 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,334,802 | 105,721 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,704,065 | 51,374 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,629,229 | 49,337 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,426,906 | 51,301 | Shares | Defined | 2023-02-14 | |
| 2021-06-30 | $818,403 | 10,000 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $951,029 | 10,000 | Call | Defined | 2021-05-17 | |
| 2021-03-31 | $606,471 | 6,377 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,065,308 | 33,290 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,613,237 | 77,581 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,023,486 | 29,000 | Put | Defined | 2020-08-14 | |
| 2020-06-30 | $11,891,332 | 170,423 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,521,772 | 165,806 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $1,315,582 | 29,000 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||